190 related articles for article (PubMed ID: 21346004)
1. Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids.
Thakur A; Kadam RS; Kompella UB
Drug Metab Dispos; 2011 May; 39(5):771-81. PubMed ID: 21346004
[TBL] [Abstract][Full Text] [Related]
2. Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models.
Kadam RS; Cheruvu NP; Edelhauser HF; Kompella UB
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5387-99. PubMed ID: 21282583
[TBL] [Abstract][Full Text] [Related]
3. Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve.
Kadam RS; Kompella UB
J Pharmacol Exp Ther; 2010 Mar; 332(3):1107-20. PubMed ID: 19926800
[TBL] [Abstract][Full Text] [Related]
4. Notice of concern: Re: Thakur A, Kadam RS, and Kompella UB (2011) Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids. Drug Metab Dispos 39:771-781; doi:10.1124/dmd.110.037408.
Drug Metab Dispos; 2015 Feb; 43(2):298. PubMed ID: 25581726
[No Abstract] [Full Text] [Related]
5. Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.
Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4513-22. PubMed ID: 17003447
[TBL] [Abstract][Full Text] [Related]
6. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration.
Amrite AC; Edelhauser HF; Singh SR; Kompella UB
Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929
[TBL] [Abstract][Full Text] [Related]
7. Hydrophilic prodrug approach for reduced pigment binding and enhanced transscleral retinal delivery of celecoxib.
Malik P; Kadam RS; Cheruvu NP; Kompella UB
Mol Pharm; 2012 Mar; 9(3):605-14. PubMed ID: 22256989
[TBL] [Abstract][Full Text] [Related]
8. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an ex vivo model implication for carrier-mediated retinal drug delivery.
Kansara V; Mitra AK
Curr Eye Res; 2006 May; 31(5):415-26. PubMed ID: 16714233
[TBL] [Abstract][Full Text] [Related]
10. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
Ranta VP; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
[TBL] [Abstract][Full Text] [Related]
11. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.
Pitkänen L; Ranta VP; Moilanen H; Urtti A
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):641-6. PubMed ID: 15671294
[TBL] [Abstract][Full Text] [Related]
12. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
Li J; Lan B; Li X; Sun S; Lu P; Cheng L
J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
[TBL] [Abstract][Full Text] [Related]
13. Effect of benzalkonium chloride on transscleral drug delivery.
Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
[TBL] [Abstract][Full Text] [Related]
14. Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.
Vooturi SK; Kadam RS; Kompella UB
Mol Pharm; 2012 Nov; 9(11):3136-46. PubMed ID: 23003105
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
[TBL] [Abstract][Full Text] [Related]
16. The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide.
Du W; Sun S; Xu Y; Li J; Zhao C; Lan B; Chen H; Cheng L
J Ocul Pharmacol Ther; 2013 Sep; 29(7):633-8. PubMed ID: 23597073
[TBL] [Abstract][Full Text] [Related]
17. Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes.
Kadam RS; Williams J; Tyagi P; Edelhauser HF; Kompella UB
Mol Vis; 2013; 19():1198-210. PubMed ID: 23734089
[TBL] [Abstract][Full Text] [Related]
18. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
19. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
[TBL] [Abstract][Full Text] [Related]
20. Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery.
Amaral J; Fariss RN; Campos MM; Robison WG; Kim H; Lutz R; Becerra SP
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4383-92. PubMed ID: 16303924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
